ATE318142T1 - Verwendung von spezifischen 'steady-state' calcium-r-kanalblockern - Google Patents

Verwendung von spezifischen 'steady-state' calcium-r-kanalblockern

Info

Publication number: ATE318142T1
Authority: AT; Austria
Prior art keywords: channel blockers; steady; state; calcium; specific
Prior art date: 1997-09-30

Application number

AT98944936T

Other languages

English (en)

Inventor

Ghassan Bkaily

Orleans-Juste Pedro D

Joao B Calixto

Rosendo A Yunes

Original Assignee

Univ Sherbrooke

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-30

Filing date

1998-09-28

Publication date

2006-03-15

1998-09-28 Application filed by Univ Sherbrooke filed Critical Univ Sherbrooke

2006-03-15 Application granted granted Critical

2006-03-15 Publication of ATE318142T1 publication Critical patent/ATE318142T1/de

Links

230000007170 pathology Effects 0.000 abstract 2
HMJIYCCIJYRONP-UHFFFAOYSA-N (+-)-Isradipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC2=NON=C12 HMJIYCCIJYRONP-UHFFFAOYSA-N 0.000 abstract 1
241000511969 Mandevilla Species 0.000 abstract 1
241000544513 Mandevilla illustris Species 0.000 abstract 1
241000544528 Mandevilla pohliana Species 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229960004427 isradipine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/003—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Saccharide Compounds (AREA)
Oscillators With Electromechanical Resonators (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT98944936T 1997-09-30 1998-09-28 Verwendung von spezifischen 'steady-state' calcium-r-kanalblockern ATE318142T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA002217088A CA2217088A1 (en)	1997-09-30	1997-09-30	New mandevilla velutina derivatives as steady-state r-type ca2+ channel blockers, method of making and use thereof

Publications (1)

Publication Number	Publication Date
ATE318142T1 true ATE318142T1 (de)	2006-03-15

Family

ID=4161555

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98944936T ATE318142T1 (de)	1997-09-30	1998-09-28	Verwendung von spezifischen 'steady-state' calcium-r-kanalblockern

Country Status (7)

Country	Link
EP (1)	EP1028734B1 (de)
AT (1)	ATE318142T1 (de)
AU (1)	AU9248998A (de)
BR (1)	BR9812579A (de)
CA (1)	CA2217088A1 (de)
DE (1)	DE69833557T2 (de)
WO (1)	WO1999016449A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9923076D0 (en)	1999-09-29	1999-12-01	Phytopharm Plc	Sapogenin derivatives and their use
BR0107933A (pt) *	2000-01-28	2004-01-06	Procter & Gamble	Compostos de arginina saborosos e seus usos para saúde cardiovascular
US9808011B2 (en)	2014-12-15	2017-11-07	Biovectra Inc.	Pentacyclic triterpene compounds and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0359310A1 (de) *	1988-09-15	1990-03-21	The Procter & Gamble Company	Mandevilla-pentlandiana-Extrakte als Bradykininantagonist

1997
- 1997-09-30 CA CA002217088A patent/CA2217088A1/en not_active Abandoned
1998
- 1998-09-28 AT AT98944936T patent/ATE318142T1/de not_active IP Right Cessation
- 1998-09-28 EP EP98944936A patent/EP1028734B1/de not_active Expired - Lifetime
- 1998-09-28 BR BR9812579-6A patent/BR9812579A/pt not_active Application Discontinuation
- 1998-09-28 AU AU92489/98A patent/AU9248998A/en not_active Abandoned
- 1998-09-28 DE DE69833557T patent/DE69833557T2/de not_active Expired - Lifetime
- 1998-09-28 WO PCT/CA1998/000908 patent/WO1999016449A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO1999016449A1 (en)	1999-04-08
EP1028734A1 (de)	2000-08-23
BR9812579A (pt)	2000-07-25
DE69833557T2 (de)	2006-10-05
CA2217088A1 (en)	1999-03-30
EP1028734B1 (de)	2006-02-22
AU9248998A (en)	1999-04-23
DE69833557D1 (de)	2006-04-27

Similar Documents

Publication	Publication Date	Title
DE69817446D1 (de)	2003-10-02	Behandlung von diabetes
DE69925306D1 (de)	2005-06-16	Behandlung von kohlenwasserstoffgas
ATE291427T1 (de)	2005-04-15	Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms
ATE291897T1 (de)	2005-04-15	Verwendung von zusammensetzungen mit stabilisierten enzymen
ATE260332T1 (de)	2004-03-15	Behandlung von textilien
EP0877793A4 (de)	1999-03-03	Klonierte dioxygenase von p-hydroxyphenyl-brenztraubensäure aus pflanzen.
DE69722681D1 (de)	2003-07-10	Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
DE69623472D1 (de)	2002-10-10	Derivate von dolastatin, dreen herstellung un verwendung
DE59611411D1 (de)	2007-02-22	Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
DE69634951D1 (de)	2005-08-25	Topische verwendung von betulinsäure zur behandlung bösartiger melanome
DE69907146T2 (de)	2004-01-29	Direkte oxidation von cycloalkanen
DE69708848D1 (de)	2002-01-17	Mischung von erdalkalialkylarylsulfonaten, ihre verwendung als schmierölzusatz und herstellungsmethode
DE69628195D1 (de)	2003-06-18	Verwendung von xyloglucanendotransglycosylase
DE59609043D1 (de)	2002-05-16	Feste Lösungen von 1,4-Diketopyrrolopyrrolen
DE122007000051I2 (de)	2009-02-19	Kristallmodifikation von 1-(2,6-difluorbenzyl) -1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum
DE69926485D1 (de)	2005-09-08	Behandlung von durchblasgasen
DE69708416D1 (de)	2002-01-03	Karbothermische Herstellung von Alkalimetallen
ATE209891T1 (de)	2001-12-15	Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis
ATE318142T1 (de)	2006-03-15	Verwendung von spezifischen 'steady-state' calcium-r-kanalblockern
TR199700547A2 (xx)	1998-01-21	N-asetonilbenzamid fungisitler.
DE3751362D1 (de)	1995-07-27	5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.
DE69918541D1 (de)	2004-08-12	Verwendung von nmda antagonisten zur behandlung des reizkolons
DE59706407D1 (de)	2002-03-21	Verwendung von polyether-pur für sicherheitskleidung
DE69917445D1 (de)	2004-06-24	Reinigung von carboxaldehyd
DE59808166D1 (de)	2003-06-05	Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum

Legal Events

Date	Code	Title	Description
2006-08-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties